SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · IEX Real-Time Price · USD
9.31
+0.53 (6.04%)
May 1, 2024, 3:59 PM EDT - Market closed
SIGA Technologies Revenue
In the year 2023, SIGA Technologies had annual revenue of $139.92M with 26.31% growth. Revenue in the quarter ending December 31, 2023 was $116.48M with 925.53% year-over-year growth.
Revenue (ttm)
$139.92M
Revenue Growth
+26.31%
P/S Ratio
4.54
Revenue / Employee
$3,109,272
Employees
45
Market Cap
662.22M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 139.92M | 29.14M | 26.31% |
Dec 31, 2022 | 110.78M | -22.89M | -17.13% |
Dec 31, 2021 | 133.67M | 8.71M | 6.97% |
Dec 31, 2020 | 124.96M | 98.22M | 367.28% |
Dec 31, 2019 | 26.74M | -450.31M | -94.39% |
Dec 31, 2018 | 477.05M | 464.78M | 3,788.30% |
Dec 31, 2017 | 12.27M | -2.72M | -18.14% |
Dec 31, 2016 | 14.99M | 6.81M | 83.32% |
Dec 31, 2015 | 8.18M | 5.04M | 160.39% |
Dec 31, 2014 | 3.14M | -2.38M | -43.11% |
Dec 31, 2013 | 5.52M | -3.45M | -38.48% |
Dec 31, 2012 | 8.97M | -3.75M | -29.51% |
Dec 31, 2011 | 12.73M | -6.49M | -33.77% |
Dec 31, 2010 | 19.22M | 5.40M | 39.13% |
Dec 31, 2009 | 13.81M | 5.75M | 71.24% |
Dec 31, 2008 | 8.07M | 1.37M | 20.41% |
Dec 31, 2007 | 6.70M | -558.82K | -7.70% |
Dec 31, 2006 | 7.26M | -1.22M | -14.38% |
Dec 31, 2005 | 8.48M | 6.64M | 360.90% |
Dec 31, 2004 | 1.84M | 1.11M | 151.34% |
Dec 31, 2003 | 731.74K | 387.29K | 112.44% |
Dec 31, 2002 | 344.45K | -815.05K | -70.29% |
Dec 28, 2001 | 1.16M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 2.02B |
The Pennant Group | 544.89M |
Treace Medical Concepts | 187.12M |
Quanterix | 122.37M |
Exscientia | 25.42M |
Dianthus Therapeutics | 2.83M |
Autolus Therapeutics | 1.70M |
SIGA News
- 4 weeks ago - SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX® - GlobeNewsWire
- 7 weeks ago - SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023 - GlobeNewsWire
- 7 weeks ago - SIGA Declares Special Cash Dividend of $0.60 Per Share - GlobeNewsWire
- 2 months ago - SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer - GlobeNewsWire
- 6 months ago - SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023 - GlobeNewsWire
- 6 months ago - SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results - GlobeNewsWire
- 6 months ago - SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating Countries - GlobeNewsWire